81 related articles for article (PubMed ID: 8320124)
1. [Comment on the contribution by G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Kölmel KF; Abel U
Hautarzt; 1993 May; 44(5):329-30. PubMed ID: 8320124
[No Abstract] [Full Text] [Related]
2. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
[TBL] [Abstract][Full Text] [Related]
3. [Bowenoid actinic keratosis: therapy with intralesional injection of recombinant beta-interferon].
Kowalzick L; Mensing H; Weyer U; Kimmig W; Brzoska J
Hautarzt; 1992 Jun; 43(6):373-5. PubMed ID: 1628972
[TBL] [Abstract][Full Text] [Related]
4. [Interferon therapy in malignant melanoma].
Stadler R; Garbe C
Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
[TBL] [Abstract][Full Text] [Related]
5. Intralesional therapy of metastatic spreading melanoma with beta-interferon.
Rapprich H; Hagedorn M
J Dtsch Dermatol Ges; 2006 Sep; 4(9):743-6. PubMed ID: 16928243
[TBL] [Abstract][Full Text] [Related]
6. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Second comment].
Gefeller O; Kleeberg U; Kölmel KF
Hautarzt; 1994 Mar; 45(3):191-2; author reply 193-4. PubMed ID: 8175352
[No Abstract] [Full Text] [Related]
7. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. First comment].
Windeler J; Lange S; Trampisch HJ
Hautarzt; 1994 Mar; 45(3):189-90; author reply 193-4. PubMed ID: 8175351
[No Abstract] [Full Text] [Related]
8. Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.
Kubo H; Ashida A; Matsumoto K; Kageshita T; Yamamoto A; Saida T
Arch Dermatol Res; 2008 Jul; 300(6):297-301. PubMed ID: 18324409
[TBL] [Abstract][Full Text] [Related]
9. Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection.
Paul E; Müller I; Renner H; Bödeker RH; Cochran AJ
Melanoma Res; 2003 Dec; 13(6):611-7. PubMed ID: 14646625
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
Mastrangelo MJ; Maguire HC; Eisenlohr LC; Laughlin CE; Monken CE; McCue PA; Kovatich AJ; Lattime EC
Cancer Gene Ther; 1999; 6(5):409-22. PubMed ID: 10505851
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
[TBL] [Abstract][Full Text] [Related]
12. [Present status and problems in the therapy of malignant melanoma].
Nakayama J
Fukuoka Igaku Zasshi; 1995 Jan; 86(1):1-5. PubMed ID: 7698716
[No Abstract] [Full Text] [Related]
13. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
Beiteke U; Ruppert P; Garbe C; Oxenfarth R; Kastl I; Türker T; Tronnier H; Frosch PJ
Hautarzt; 1993 Jun; 44(6):365-71. PubMed ID: 8335459
[TBL] [Abstract][Full Text] [Related]
14. Intralesional monoclonal antibodies effective against melanoma.
Oncology (Williston Park); 1991 Apr; 5(4):56. PubMed ID: 1831040
[No Abstract] [Full Text] [Related]
15. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
Elkordy M; Crump M; Vredenburgh JJ; Petros WP; Hussein A; Rubin P; Ross M; Gilbert C; Modlin C; Meisenberg B; Coniglio D; Rabinowitz J; Laughlin M; Kurtzberg J; Peters WP
Bone Marrow Transplant; 1997 Feb; 19(4):315-22. PubMed ID: 9051240
[TBL] [Abstract][Full Text] [Related]
16. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
[TBL] [Abstract][Full Text] [Related]
17. Cellulitis-like skin necrosis induced by postoperative local interferon-β injection for malignant melanoma on the buttock.
Mori T; Ohashi T; Kikuchi N; Hanami Y; Yamamoto T
J Dermatol; 2014 Apr; 41(4):364-5. PubMed ID: 24690105
[No Abstract] [Full Text] [Related]
18. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
[TBL] [Abstract][Full Text] [Related]
19. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
[TBL] [Abstract][Full Text] [Related]
20. Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma.
Gutwald JG; Groth W; Mahrle G
Br J Dermatol; 1994 Apr; 130(4):541-2. PubMed ID: 8186129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
